Avalyn Pharma Inc. Common Stock
- AVLN
- NASDAQ
- Biotechnology
- Pulmonary Fibrosis Therapeutics
- Inhaled Drug Delivery
- Rare Disease Biotech
$23.66
Today −3.98%Quote Oct 16, 2026, 08:00 PM UTC
−29.23%over the last month
Max drawdown −29.2%From 1-month high −29.2%3 months −17.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.05B
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$60.00
+153.6% from here
Floor
$22.68
4.1% below price
Where the price sits
1 analyst
Analyst range, low to high
$51.00$80.00
- Price $23.66
- Resistance $23.86
- Consensus $60.00
The price is right under resistance. Analysts' average target sits about 154% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AVLNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
55